glucose, (beta-d)-isomer has been researched along with chlorhexidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lehtonen, OP; Peltola, O; Vaahtoranta-Lehtonen, HH | 1 |
| Harvima, I; Lehtonen, OP; Nikoskelainen, E; Peltola, O; Vaahtoranta-Lehtonen, HH | 1 |
| Dogru, Y; Salmanli, M; Tatar, G; Tuzuner, T | 1 |
2 trial(s) available for glucose, (beta-d)-isomer and chlorhexidine
| Article | Year |
|---|---|
Contact lens care using chlorhexidine acetate with ethyl-6-O-decanoyl-glucoside: a comparative clinical and bacteriological study.
Topics: Adult; Bacteria; Bacteriological Techniques; Biguanides; Chlorhexidine; Conjunctiva; Conjunctivitis, Bacterial; Contact Lens Solutions; Contact Lenses, Hydrophilic; Cornea; Detergents; Double-Blind Method; Drug Combinations; Eye Infections, Bacterial; Female; Follow-Up Studies; Glucosides; Humans; Keratitis; Male; Preservatives, Pharmaceutical | 1997 |
Papillary hypertrophy of the upper tarsal conjunctiva during contact lens wear: a 4-month study with ethyl-6-O-decanoyl-glucoside.
Topics: Adult; Angiogenesis Inducing Agents; Biomarkers; Chlorhexidine; Chymases; Conjunctiva; Conjunctival Diseases; Contact Lens Solutions; Contact Lenses, Extended-Wear; Detergents; Disinfectants; Drug Therapy, Combination; Eye Proteins; Eyelids; Female; Follow-Up Studies; Glucosides; Humans; Hypertrophy; Male; Serine Endopeptidases; Tears; Tryptases | 1999 |
1 other study(ies) available for glucose, (beta-d)-isomer and chlorhexidine
| Article | Year |
|---|---|
Evaluation of the effects of chlorhexidine and several flavonoids as antiviral purposes on SARS-CoV-2 main protease: molecular docking, molecular dynamics simulation studies.
Topics: Antiviral Agents; Chlorhexidine; Coronavirus 3C Proteases; COVID-19 Drug Treatment; Flavonoids; Glucosides; Humans; Kaempferols; Molecular Docking Simulation; Molecular Dynamics Simulation; Protease Inhibitors; Quercetin; Rutin; SARS-CoV-2; Viral Nonstructural Proteins | 2022 |